Composite Lymphoma

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Composite Lymphoma trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (4 shown)

Active — Not RecruitingPhase 1/2

NCT05025800

ALX148, Rituximab and Lenalidomide for the Treatment of Indolent and Aggressive B-cell Non-Hodgkin Lymphoma

This phase I/II trial finds out the best dose, possible benefits and/or side effects of ALX148 in combination with rituximab and lenalidomide in treating patien…

United States47 participantsStarted 2021-10-13

Treatment: CD47 Antagonist ALX148, Lenalidomide

Not Yet RecruitingPhase 2

NCT07007052

Phase II Study Evaluating the Efficacy and Safety of the Combination of Tagraxofusp and Venetoclax in Treatment-naive Bl…

The goal of this clinical trial is to study the efficacy of the tagraxofusp + venetoclax combination in treatment-naive blastic plasmacytoid dendritic cell neop…

France33 participantsStarted 2025-12-01

Treatment: Venetoclax, Tagraxofusp

CompletedPhase 1

NCT02541565

Pembrolizumab and Combination Chemotherapy in Treating Patients With Previously Untreated Diffuse Large B-cell Lymphoma…

This pilot phase I trial studies the side effects of pembrolizumab and combination chemotherapy in treating patients with previously untreated diffuse large B-c…

United States30 participantsStarted 2015-11-24

Treatment: Cyclophosphamide, Doxorubicin Hydrochloride

UnknownNot Applicable

NCT02927756

Italian Multicenter Retrospective Observational Study on Transformed Lymphomas

Study purpose is to evaluate treatment outcome and survival in patient with aggressive lymphomas transformed from Follicular Lymphoma.

Italy180 participantsStarted 2017-11